Alopecia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently published an extensive report on the global Alopecia Treatment Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

Alopecia Treatment Market Size (2024E): USD 11.1 Bn
Projected Market Value (2033F): USD 25.6 Bn
Global Market Growth Rate (CAGR 2024 to 2033): 9.80%

Alopecia Treatment Market - Report Scope:

The Alopecia Treatment Market encompasses a variety of products and therapies aimed at treating different forms of hair loss, including androgenetic alopecia, alopecia areata, and telogen effluvium. These treatments range from pharmaceutical solutions like minoxidil and finasteride to surgical options such as hair transplants. The market serves diverse segments, including dermatology clinics, pharmacies, online platforms, and cosmetic surgery centers. Growth is driven by increasing awareness about hair loss treatments, advancements in medical technology, and the expanding application of novel therapeutic approaches across various patient demographics.

Market Growth Drivers:

Several key factors are driving the global Alopecia Treatment Market. The rising prevalence of hair loss conditions among both men and women boosts the demand for effective treatment solutions. Technological advancements in hair restoration techniques, such as follicular unit extraction (FUE) and platelet-rich plasma (PRP) therapy, further fuel the market's expansion. Additionally, the growing consumer focus on aesthetic appearance and the availability of non-invasive treatment options drive the demand for alopecia treatments. Enhanced research and development activities, along with the introduction of personalized treatment plans, contribute to market growth by offering more tailored solutions for patients with different types and severities of alopecia.

Market Restraints:

Despite promising growth prospects, the Alopecia Treatment Market faces challenges related to the high costs of advanced treatment options and the potential side effects associated with certain pharmaceutical solutions. Market growth can be hindered by the availability of alternative treatments, such as natural remedies and over-the-counter products, which may be preferred by some consumers due to their lower cost and perceived safety. Additionally, the stigma associated with hair loss and the reluctance of some patients to seek treatment pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve treatment efficacy, reduce side effects, and lower costs.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of personalized medicine and the rising demand for innovative, non-invasive treatment options. The development of advanced therapies, such as stem cell therapy and gene therapy, caters to the growing need for more effective and long-lasting hair restoration solutions. The expansion of telemedicine platforms and online consultation services provides new channels for market growth, allowing companies to reach a broader audience and offer convenient access to treatment options. Strategic partnerships, investments in new technologies, and the introduction of combination therapies are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Alopecia Treatment Market globally?
Which types and applications of alopecia treatments are leading the adoption in various settings?
How are technological advancements influencing the competitive landscape of the Alopecia Treatment Market?
Who are the key players in the Alopecia Treatment Market, and what strategies are they employing to stay competitive?
What are the emerging trends and future prospects in the global Alopecia Treatment Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Alopecia Treatment Market, including Johnson & Johnson, Merck & Co., and L'Oreal S.A., focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced alopecia treatment solutions and explore new therapeutic approaches. Collaborations with academic institutions, research organizations, and industry stakeholders facilitate market access and promote new product adoption. Emphasis on consumer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Alopecia Treatment Market landscape.

Key Companies Profiled:

Elli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Johnson & Johnson, Inc.
Dr. Reddy's Laboratories Ltd.
Cipla Ltd.
Cellmid Ltd.
The Himalaya Drug Company
Taisho Pharmaceutical Holdings Co., Ltd
Shiseido Co., Ltd.
Zhangguang 101 Science & Technology Co., Ltd.
Pfizer
Thera dome
LUTRONIC
Curallux

Alopecia Treatment Market Industry Segmentation

By Treatment Type:

Topical Drugs
Oral Drugs
Injectable
Hair Transplant Services
Low-Level Laser Therapy

By End User:

Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Product Code: PMRREP9677

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Treatment Type Innovation / Development Trends

4. Key Success Factors

4.1. Treatment Type Adoption / Usage Analysis
4.2. List of Suppliers & Distributors- By Region
4.3. Consumer Sentiment Analysis
4.4. Porter's Analysis
4.5. PESTEL Analysis
4.6. Regulatory Scenario
4.7. Value Chain Analysis
4.8. Promotional Strategies, By Key Players
4.9. Pipeline Analysis
4.10. Disease Epidemiology
4.11. Parent Market Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Top Companies' Historical Growth
- 5.2.2. Rising Prevalence of Alopecia
- 5.2.3. Growing Investment in Healthcare Expenditure
- 5.2.4. Innovation and Development
- 5.2.5. Cost of New Drugs
- 5.2.6. Adoption of Organic Treatment Types
- 5.2.7. Increased Pipeline Treatment Types
5.3. Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Treatment Type
- 6.1.2. By End User
- 6.1.3. By Region
6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Treatment Type

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Treatment Type, 2019-2023
8.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Treatment Type, 2024-2033
- 8.3.1. Topical Drugs
  - 8.3.1.1. Creams
  - 8.3.1.2. Oils
  - 8.3.1.3. Gels
  - 8.3.1.4. Shampoo
  - 8.3.1.5. Lotion
  - 8.3.1.6. Foam
- 8.3.2. Oral Drugs
- 8.3.3. Injectables
  - 8.3.3.1. Platelet Rich Plasma
  - 8.3.3.2. Steroid Injections
  - 8.3.3.3. Injectable Filler
- 8.3.4. Hair Transplant Services
- 8.3.5. Low-Level Laser Therapy
8.4. Market Attractiveness Analysis By Treatment Type

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
- 9.3.1. Hospitals
- 9.3.2. Dermatologic and Trichology Clinics
- 9.3.3. Home care settings
- 9.3.4. Aesthetic Clinics
9.4. Market Attractiveness Analysis By End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

10.1. Introduction
10.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
10.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. South Asia
- 10.3.5. East Asia
- 10.3.6. Oceania
- 10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
11.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Treatment Type
- 11.3.3. By End User
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Treatment Type
- 11.4.3. By End User
11.5. Country Level Analysis & Forecast
- 11.5.1. U.S. Market Analysis
  - 11.5.1.1. .Introduction
  - 11.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.5.1.2.1. By Treatment Type
    - 11.5.1.2.2. By End User
- 11.5.2. Canada Market Analysis
  - 11.5.2.1. Introduction
  - 11.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.5.2.2.1. By Treatment Type
    - 11.5.2.2.2. By End User
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
12.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. Brazil
  - 12.3.1.2. Mexico
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of Latin America
- 12.3.2. By Treatment Type
- 12.3.3. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment Type
- 12.4.3. By End User
12.5. Country Level Analysis & Forecast
- 12.5.1. Brazil Market Analysis
  - 12.5.1.1. .Introduction
  - 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.1.2.1. By Treatment Type
    - 12.5.1.2.2. By End User
- 12.5.2. Mexico Market Analysis
  - 12.5.2.1. Introduction
  - 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.2.2.1. By Treatment Type
    - 12.5.2.2.2. By End User
- 12.5.3. Argentina Market Analysis
  - 12.5.3.1. Introduction
  - 12.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.3.2.1. By Treatment Type
    - 12.5.3.2.2. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
13.3. Market Size (US$ Bn) and Volume (Units) Forecast, By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. France
  - 13.3.1.3. Italy
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. Russia
  - 13.3.1.7. BENELUX
  - 13.3.1.8. Nordic Countries
  - 13.3.1.9. Rest of Europe
- 13.3.2. By Treatment Type
- 13.3.3. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment Type
- 13.4.3. By End User
13.5. Country Level Analysis & Forecast
- 13.5.1. Germany Market Analysis
  - 13.5.1.1. .Introduction
  - 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.1.2.1. By Treatment Type
    - 13.5.1.2.2. By End User
- 13.5.2. France Market Analysis
  - 13.5.2.1. Introduction
  - 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.2.2.1. By Treatment Type
    - 13.5.2.2.2. By End User
- 13.5.3. Italy Market Analysis
  - 13.5.3.1. Introduction
  - 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.3.2.1. By Treatment Type
    - 13.5.3.2.2. By End User
- 13.5.4. U.K. Market Analysis
  - 13.5.4.1. .Introduction
  - 13.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.4.2.1. By Treatment Type
    - 13.5.4.2.2. By End User
- 13.5.5. Spain Market Analysis
  - 13.5.5.1. .Introduction
  - 13.5.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.5.2.1. By Treatment Type
    - 13.5.5.2.2. By End User
- 13.5.6. Russia Market Analysis
  - 13.5.6.1. .Introduction
  - 13.5.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.6.2.1. By Treatment Type
    - 13.5.6.2.2. By End User
- 13.5.7. Nordic Countries Market Analysis
  - 13.5.7.1. .Introduction
  - 13.5.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.7.2.1. By Treatment Type
    - 13.5.7.2.2. By End User
- 13.5.8. BENELUX Market Analysis
  - 13.5.8.1. .Introduction
  - 13.5.8.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.8.2.1. By Treatment Type
    - 13.5.8.2.2. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
14.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. India
  - 14.3.1.2. Thailand
  - 14.3.1.3. Indonesia
  - 14.3.1.4. Malaysia
  - 14.3.1.5. Rest of South Asia
- 14.3.2. By Treatment Type
- 14.3.3. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment Type
- 14.4.3. By End User
14.5. Country Level Analysis & Forecast
- 14.5.1. India Market Analysis
  - 14.5.1.1. .Introduction
  - 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.1.2.1. By Treatment Type
    - 14.5.1.2.2. By End User
- 14.5.2. Thailand Market Analysis
  - 14.5.2.1. .Introduction
  - 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.2.2.1. By Treatment Type
    - 14.5.2.2.2. By End User
- 14.5.3. Indonesia Market Analysis
  - 14.5.3.1. Introduction
  - 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.3.2.1. By Treatment Type
    - 14.5.3.2.2. By End User
- 14.5.4. Malaysia Market Analysis
  - 14.5.4.1. Introduction
  - 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.4.2.1. By Treatment Type
    - 14.5.4.2.2. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
15.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Treatment Type
- 15.3.3. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment Type
- 15.4.3. By End User
15.5. Country Level Analysis & Forecast
- 15.5.1. China Market Analysis
  - 15.5.1.1. .Introduction
  - 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.1.2.1. By Treatment Type
    - 15.5.1.2.2. By End User
- 15.5.2. Japan Market Analysis
  - 15.5.2.1. Introduction
  - 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.2.2.1. By Treatment Type
    - 15.5.2.2.2. By End User
- 15.5.3. South Korea Market Analysis
  - 15.5.3.1. Introduction
  - 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.3.2.1. By Treatment Type
    - 15.5.3.2.2. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
16.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Treatment Type
- 16.3.3. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment Type
- 16.4.3. By End User
16.5. Country Level Analysis & Forecast
- 16.5.1. Australia Market Analysis
  - 16.5.1.1. .Introduction
  - 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.1.2.1. By Treatment Type
    - 16.5.1.2.2. By End User
- 16.5.2. New Zealand Market Analysis
  - 16.5.2.1. Introduction
  - 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.2.2.1. By Treatment Type
    - 16.5.2.2.2. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
17.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkiye
  - 17.3.1.3. Northern Africa
  - 17.3.1.4. South Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Treatment Type
- 17.3.3. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment Type
- 17.4.3. By Material
- 17.4.4. By Indication
- 17.4.5. By End User
17.5. Country Level Analysis & Forecast
- 17.5.1. GCC Countries Market Analysis
  - 17.5.1.1. .Introduction
  - 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.1.2.1. By Treatment Type
    - 17.5.1.2.2. By End User
- 17.5.2. Turkiye Market Analysis
  - 17.5.2.1. Introduction
  - 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.2.2.1. By Treatment Type
    - 17.5.2.2.2. By End User
- 17.5.3. Northern Africa Market Analysis
  - 17.5.3.1. Introduction
  - 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.3.2.1. By Treatment Type
    - 17.5.3.2.2. By End User
- 17.5.4. South Africa Market Analysis
  - 17.5.4.1. Introduction
  - 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.4.2.1. By Treatment Type
    - 17.5.4.2.2. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
- 19.3.1. Elli Lilly and Company
  - 19.3.1.1. Overview
  - 19.3.1.2. Treatment Type Portfolio
  - 19.3.1.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.1.4. Sales Footprint
  - 19.3.1.5. Strategy Overview
- 19.3.2. Teva Pharmaceutical Industries Ltd.
  - 19.3.2.1. Overview
  - 19.3.2.2. Treatment Type Portfolio
  - 19.3.2.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.2.4. Sales Footprint
  - 19.3.2.5. Strategy Overview
- 19.3.3. Merck & Co., Inc.
  - 19.3.3.1. Overview
  - 19.3.3.2. Treatment Type Portfolio
  - 19.3.3.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.3.4. Sales Footprint
  - 19.3.3.5. Strategy Overview
- 19.3.4. Johnson & Johnson, Inc.
  - 19.3.4.1. Overview
  - 19.3.4.2. Treatment Type Portfolio
  - 19.3.4.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.4.4. Sales Footprint
  - 19.3.4.5. Strategy Overview
- 19.3.5. Dr. Reddy's Laboratories Ltd.
  - 19.3.5.1. Overview
  - 19.3.5.2. Treatment Type Portfolio
  - 19.3.5.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.5.4. Sales Footprint
  - 19.3.5.5. Strategy Overview
- 19.3.6. Cipla Ltd.
  - 19.3.6.1. Overview
  - 19.3.6.2. Treatment Type Portfolio
  - 19.3.6.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.6.4. Sales Footprint
  - 19.3.6.5. Strategy Overview
- 19.3.7. Cellmid Ltd.
  - 19.3.7.1. Overview
  - 19.3.7.2. Treatment Type Portfolio
  - 19.3.7.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.7.4. Sales Footprint
  - 19.3.7.5. Strategy Overview
- 19.3.8. The Himalaya Drug Company
  - 19.3.8.1. Overview
  - 19.3.8.2. Treatment Type Portfolio
  - 19.3.8.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.8.4. Sales Footprint
  - 19.3.8.5. Strategy Overview
- 19.3.9. Taisho Pharmaceutical Holdings Co., Ltd
  - 19.3.9.1. Overview
  - 19.3.9.2. Treatment Type Portfolio
  - 19.3.9.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.9.4. Sales Footprint
  - 19.3.9.5. Strategy Overview
- 19.3.10. Shiseido Co., Ltd.
  - 19.3.10.1. Overview
  - 19.3.10.2. Treatment Type Portfolio
  - 19.3.10.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.10.4. Sales Footprint
  - 19.3.10.5. Strategy Overview
- 19.3.11. Zhangguang 101 Science & Technology Co., Ltd.
  - 19.3.11.1. Overview
  - 19.3.11.2. Treatment Type Portfolio
  - 19.3.11.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.11.4. Sales Footprint
  - 19.3.11.5. Strategy Overview
- 19.3.12. Pfizer
  - 19.3.12.1. Overview
  - 19.3.12.2. Treatment Type Portfolio
  - 19.3.12.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.12.4. Sales Footprint
  - 19.3.12.5. Strategy Overview
- 19.3.13. Thera dome
  - 19.3.13.1. Overview
  - 19.3.13.2. Treatment Type Portfolio
  - 19.3.13.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.13.4. Sales Footprint
  - 19.3.13.5. Strategy Overview
- 19.3.14. LUTRONIC
  - 19.3.14.1. Overview
  - 19.3.14.2. Treatment Type Portfolio
  - 19.3.14.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.14.4. Sales Footprint
  - 19.3.14.5. Strategy Overview
- 19.3.15. Curallux
  - 19.3.15.1. Overview
  - 19.3.15.2. Treatment Type Portfolio
  - 19.3.15.3. Profitability by Market Segments (Treatment Type/Region)
  - 19.3.15.4. Sales Footprint
  - 19.3.15.5. Strategy Overview